Biocon, DKSH collaborate to commercialise seven generic formulations in Singapore, Thailand
Biocon, DKSH collaborate to commercialise seven generic formulations in Singapore, Thailand
Biocon’s subsidiary, Biocon Pharma Restricted, and DKSH Enterprise Unit Healthcare, signed an settlement beneath which DKSH will promote and distribute seven of Biocon Pharma’s generic formulations in Singapore and Thailand.
DKSH will acquire an unique licence to register and commercialise the seven generic formulations from numerous therapeutic areas like diabetology, cardiology, oncology and…
View On WordPress










